Middle East Blood Plasma Derivatives Market Size to Reach $3.0 Billion, by 2031 at 9.4% CAGR: Allied Market Research

News provided by

Jan 30, 2023, 01:26 ET

Alarming rise in prevalence of life-threatening diseases such as immunodeficient diseases, bleeding disorders, increase in number of blood donations. and increase in number of geriatric population drive the growth of the global middle east blood plasma derivatives market

PORTLAND, Ore., Jan. 30, 2023 /PRNewswire/ -- Allied Market Research published a report, titled, "Middle East Blood Plasma Derivatives Market by Type (Albumin, Factor VII, Factor IX Concentrate, Anti-Coagulation Factor, Rh Immunoglobulin, and Others), by Application (Immunodeficiency Diseases, Bleeding Disorders, Liver Conditions, and Others), by End User (Hospitals, Clinics, and Transfusion Centers): Global Opportunity Analysis and Industry Forecast, 2021-2031." According to the report, the global middle east blood plasma derivatives market generated $1.1 billion in 2021, and is estimated to reach $3.0 billion by 2031, witnessing a CAGR of 9.4% from 2022 to 2031. The report offers a detailed analysis of changing market trends, top segments, key investment pockets, value chains, regional landscapes, and competitive scenarios.

Download Free Sample Report: https://www.alliedmarketresearch.com/request-sample/53998

Drivers, Restraints, and Opportunities-

Rise in the prevalence of life-threatening disorders such as immunodeficiency disorders and hemophilia, and rise in awareness among the health professional regarding medicinal use of blood plasma drive the growth of the global middle east blood plasma derivatives market. On the other hand, side effects associated with blood plasma derivative therapy and prohibitive cost of therapy restrain the growth to some extent. However, surge in promotional activities by manufacturers and rise in awareness about usefulness of blood donation and plasma donation among individuals are expected to create lucrative opportunities in the industry.

Covid-19 scenario-

The rise in the usage of plasma derivatives for treatment of COVID-19 is anticipated to have positive impact on the middle east blood plasma derivative market. Moreover, rise in the number of blood donation and plasma donation activity during COVID-19 is anticipated to drive the growth of market.
With the emergence of the COVID-19 pandemic, the demand for plasma derivatives such as albumin, immunoglobulin, and coagulation factors has increased significantly. In addition, the availability of safe and effective plasma derivatives for a variety of medical applications has made them highly sought after in the Middle East region.

The hospitals segment to maintain its dominance during the forecast period-

By end user, the hospitals segment held the largest share in 2021, garnering nearly three-fourths of the global middle east blood plasma derivatives market revenue, and is projected to maintain its dominance by 2031. The same segment would also showcase the fastest CAGR of 9.7% during the forecast period. This is driven by the considerable number of patient visits to the hospitals for blood donation, increase in prevalence immunodeficiency disorders, & bleeding disorders and rise in number of hospitalization.

Purchase Inquiry: https://www.alliedmarketresearch.com/purchase-enquiry/53998

The bleeding disorder segment to rule the roost-

By application, the bleeding disorder segment contributed to more than one-thirds of the global middle east blood plasma derivatives market share in 2021, and is projected to rule the roost by 2031. The same segment would also display the fastest CAGR of 9.9% throughout the forecast period. Increase in prevalence of bleeding disorder and surge in application of blood plasma derivatives for treatment of bleeding disorders in middle east fuel the segment growth.

Rest of Middle East garnered the major share in 2021-

By region, Rest of Middle East held the major share in 2021, garnering more than three-fifths of the global Middle East Blood Plasma Derivatives market revenue, and is expected to dominate by 2031. This is due to the prevalence of hemophilia, and life threating disorder. Saudi-Arabia, on the other hand, would showcase the fastest CAGR of 10.5% from 2022 to 2031.

Leading Market Players-

Bayer AG
Biotest AG
CSL Limited
Fusion Healthcare Pvt. Ltd.
Grifols, S.A.
Kedrion Biopharma, Inc.
LFB S.A.
Octapharma AG
Sanofi
Takeda Pharmaceutical Co., Ltd.

The report analyzes these key players in the global middle east blood plasma derivatives market. The report is helpful in determining the business performance, operating segments, developments, and product portfolios of every market player.

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Internet of Things in Healthcare Market by Component (Devices, System & Software, and services), Application (Patient Monitoring, Clinical Operation & Workflow Optimization, Connected Imaging, Fitness & Wellness Measurement, and Drug Development) and End User (Healthcare Providers, Patients, Healthcare Payers, Research Laboratories, and Government Authority): Global Opportunity Analysis and Industry Forecast, 2020-2030

Digital Pathology Market by Type (Scanners, Software, and Storage & Communication Systems), Application (Teleconsultation, Disease Diagnosis, Drug Discovery, and Training & Education), and End User (Educational, Clinical, and Pharma & Biotech Companies): Global Opportunity Analysis and Industry Forecast, 2021-2030

Albumin Market by Type (Human Serum Albumin, Bovine Serum, and, Recombinant Albumin) and Application (Therapeutics, Drug Formulation & Vaccines, Component of Media, and Others): Global Opportunity Analysis and Industry Forecast, 2021-2030

Gene Therapy Market by Vector Type (Viral Vector, Non Viral Vector), by Therapy (In Vivo Therapy, Ex Vivo Therapy), by Gene Type (Antigen, Cytokine, Tumor Suppressor, Suicide, Deficiency, Growth factors, Receptors, Others), by Application (Oncological Disorders, Rare Diseases, Neurological Disorders, Other Diseases): Global Opportunity Analysis and Industry Forecast, 2020-2030

Biopharmaceuticals Market By Type (Monoclonal Antibody, Interferon, Insulin, Growth & Coagulation Factor, Erythropoietin, Vaccine, Hormone, and, Others) and Application (Oncology, Blood Disorder, Metabolic Disease, Infectious Disease, Cardiovascular Disease, Neurological Disease, Immunology, and Others) - Global Opportunity Analysis And Industry Forecast, 2020-2030

Culture Media Market by Type (Lysogeny Broth, Chemically Defined Media, Classical Media, Serum-free Media, Specialty Media, Stem Cell Media, Custom Media Formulation, and Others), Application (Cancer Research, Biopharmaceuticals, Regenerative Medicine & Tissue Engineering, Stem Cell Technologies, Drug Discovery, and Others), Research Type (Cytogenetics, Cell Therapy, and Others), and End User (Biotechnology & Pharmaceutical Industry, Academic Institute, Research Laboratory, and Others):Global Opportunity Analysis and Industry Forecast, 2021-2030

Digital PCR Market by Technology (Droplet Digital Pcr, Chip Based Digital Pcr, Beaming Digital Pcr), by Product Type (Digital Pcr Systems, Consumables And Reagents, Software And Services), by Application (Research, Clinical Diagnostics, Forensic And Others), by End User (Pharmaceuticals And Biotechnology Industries, Clinical Diagnostic Laboratories, Universities And Other Organizations), : Global Opportunity Analysis and Industry Forecast, 2020-2030

Interventional Oncology Market by Product [Ablation Radiofrequency Ablation Devices, Microwave Ablation Devices, Cryoablation Devices, and Others), Particle Embolization (Radioembolic agents, Drug-Eluting Beads, and Others), Support Devices]: Global Opportunity Analysis and Industry Forecast, 2021-2031

Antibiotics Market by Class (Beta Lactam & Beta Lactamase, Quinolones, Macrolides, and Others), Drug Origin (Natural, Semisynthetic, and Synthetic), Spectrum of Activity (Broad-spectrum Antibiotic and Narrow-spectrum Antibiotic), and Route of Administration (Oral, Intravenous, and Others): Global Opportunity Analysis and Industry Forecast, 2020-2030

Gloves Market by Type (Disposable Sterile Gloves, Disposable examination and protective gloves, and Consumer gloves), and Industry (Medical, Horeca (food), Cleaning, Beauty, Food and Drinks, Pharmaceutical, Chemical, Automotive, Electronics, Construction, and Others): Global Opportunity Analysis and Industry Forecast 2021-2030

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
[email protected]
Web: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow Us on Blog: https://www.globalhealthcareindustry.com/